Item 8.01. Other Events

Determination of Estimated Per-Share Net Asset Value

Overview



The board of directors (the "Board") of Healthcare Trust, Inc. (the "Company")
has previously adopted valuation guidelines used in connection with determining
the estimated per-share net asset value ("Estimated Per-Share NAV") of the
Company's common stock. Under these guidelines, the Company publishes an
Estimated Per-Share NAV on at least an annual basis. Healthcare Trust Advisors,
LLC, the Company's advisor (the "Advisor"), calculates the Estimated Per-Share
NAV taking into consideration appraisals of the Company's real estate assets
(each asset individually, a "Real Estate Asset" and collectively, the "Real
Estate Assets") which are performed by an independent valuation firm in
accordance with the valuation guidelines. The Advisor reviews these valuations
both for consistency with the valuation guidelines and for the reasonableness of
the independent valuation firm's conclusions. The independent directors of the
Board ultimately make the final determination of Estimated Per-Share NAV. The
independent directors of the Board rely on the Advisor's input, including its
view of the estimate and the appraisals performed by the independent valuation
firm, but may, in the Board's discretion, consider other factors.

On March 31, 2023, the independent directors of the Board, who comprise a
majority of the Board unanimously approved an Estimated Per-Share NAV as of
December 31, 2022 (the "Valuation Date") equal to $14.00. The Estimated
Per-Share NAV of $14.00 selected by the independent directors of the Board fell
within the range of the values reported by Kroll, LLC (formerly known as Duff &
Phelps, LLC) ("Kroll"), an independent third-party real estate advisory firm
engaged by the Company to value its real estate assets and review the valuations
of its other assets and liabilities. The range of values provided by Kroll was
based on the estimated fair value of the Company's assets less the estimated
fair value of the Company's liabilities and the liquidation value of the
Company's 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the
"Series A Preferred Stock") and the liquidation value of the Company's 7.125%
Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B
Preferred Stock"), divided by 105,541,612 shares of common stock outstanding as
of December 31, 2022. The common stock outstanding amount used to calculate the
Estimated Per-Share NAV as of December 31, 2022 includes the dividends declared
and issued entirely in shares of the Company's common stock through December 31,
2022, but does not include any other dividend declared and payable in whole or
in part in shares of the Company's common stock subsequent to December 31, 2022.
Issuing dividends in additional shares of common stock will, all things equal,
cause the Estimated Per-Share NAV to decline because the number of shares
outstanding increases when shares of common stock are issued in respect of a
stock dividend; however, because each stockholder will receive the same
proportionate number of new shares, the total value of a common stockholder's
investment, all things equal, will not change assuming no sales or other
transfers.

In determining the Estimated Per-Share NAV of $14.00, the independent directors
of the Board considered various factors, including the information provided by
Kroll, the impact of the stock dividend that was issued in January 2023 and the
fact that properties held for sale or under contract for sale at December 31,
2022 were valued based on their contract sale prices and without giving
consideration to the reinvestment of the sale proceeds. There have been no other
changes between December 31, 2022 and the date of this filing that the Advisor
believes would materially impact the overall Estimated Per-Share NAV.

The Estimated Per-Share NAV will not be adjusted for any stock dividend(s) paid in the future until the Board determines a new Estimated Per-Share NAV.

Sensitivity Analysis



The Advisor noted that applying the low, midpoint and high ends of the range of
capitalization rates and discount rates used by Kroll resulted in an Estimated
Per-Share NAV range equal to $12.79 - $14.54 per share. The midpoint in that
range is $13.65 per share.

The capitalization rates and discount rates used have a significant impact on
the estimated value of the Real Estate Assets. The following chart presents the
impact on the Company's Estimated Per-Share NAV resulting from variations in the
capitalization rates for those properties valued using the Direct Capitalization
Method (as defined below) and variations in discount rates for those properties
valued using the Discounted Cash Flow Method (as defined below), within the
range of values determined by Kroll.

                                                      Range of Value
                                             Low         Midpoint        High
Share Price                               $ 12.79       $ 13.65       $ 14.54

Weighted Average Capitalization Rate 6.12 % 6.38 % 6.63 % Weighted Average Discount Rate (1)

           7.69  %       8.20  %       8.70  %




--------------------------------------------------------------------------------

(1)This analysis shows the effect of varying the discount rate used in the Discounted Cash Flow Method. For purposes of this sensitivity analysis, the weighted average terminal capitalization rate, which applies only to Real Estate Assets valued using the Discounted Cash Flow Method was 7.04%.

Process



Consistent with the Company's valuation guidelines, Kroll performed appraisals
of the Real Estate Assets as of the Valuation Date and provided a valuation
range for each Real Estate Asset. In addition, Kroll was engaged to review the
Company's market value estimates regarding other assets, liabilities and the
liquidation values of the outstanding shares of Series A Preferred Stock and
Series B Preferred Stock as of the Valuation Date. Kroll has extensive
experience estimating the fair value of commercial real estate.

The method used by Kroll to appraise the Real Estate Assets in the report
furnished to the Advisor and the Board by Kroll (the "Kroll Report") complies
with the Institute of Portfolio Alternatives (formerly known as the Investment
Program Association) Practice Guideline 2013-01 titled "Valuations of Publicly
Registered Non-Listed REITs," issued April 29, 2013. Also, Kroll advised that
the scope of work performed was conducted in conformity with the requirements of
the Code of Professional Ethics and Standards of Professional Practice of the
Appraisal Institute. The Company has engaged Kroll for the past six years to
assist the Board in determining the Company's Estimated Per-Share NAV. For
preparing the Kroll Report, the Company paid Kroll a customary fee for services
of this nature, no part of which was contingent relating to the provision of
services or specific findings. Other than its engagement as described herein and
its engagements to provide certain purchase price allocation and other real
estate valuation services, Kroll does not have any direct interests in any
transaction with the Company.

Potential conflicts of interest between Kroll, on one hand, and the Company or
the Advisor, on the other hand, may arise as a result of (i) the impact of the
findings of Kroll in relation to the Company's Real Estate Assets, or the assets
of real estate investment programs sponsored by affiliates of the Advisor, on
the value of ownership interests owned by, or incentive compensation payable to,
directors, officers or affiliates of the Company and the Advisor, or (ii) Kroll
performing valuation services for other programs sponsored by affiliates of the
Advisor, as well as other services for the Company. While the Company and other
programs sponsored by affiliates of the Advisor have engaged and may engage
Kroll or its affiliates in the future for valuations and real estate-related
services of various kinds, the Company believes that there are no material
conflicts of interest with respect to the Company's engagement of Kroll.

Valuation Methodology

In preparing its valuation materials and in reaching its conclusion, Kroll, among other things:

•performed its valuations on a desktop basis;

•relied on information provided by the Company relating to each property's physical, financial and economic characteristics;



•performed a study of each market to measure current market conditions, supply
and demand factors, growth patterns and their effect on each of the Real Estate
Assets;

•reviewed financial and operating information requested from, or provided by,
the Company, including property level cash flow and other leasing assumptions
for applicable Real Estate Assets;

•reviewed other assets and liabilities of the Company, including the Company's
mortgage debt, credit facilities and the liquidation values of the outstanding
shares of Series A Preferred Stock and Series B Preferred Stock; and

•performed such other analyses and studies, and considered factors, as Kroll considered appropriate.



Kroll valued the Real Estate Assets utilizing an income capitalization approach
consisting of either the Direct Capitalization Method or the Discounted Cash
Flow Method and certain other approaches, all as described further below. These
approaches are commonly used in the commercial real estate industry.

The Estimated Per-Share NAV is generally comprised of (i) the sum of (A) the
estimated value of the Real Estate Assets and (B) the estimated value of the
other assets, minus (ii) the sum of (C) the estimated value of debt and other
liabilities (D) the estimate of the aggregate incentive fees, participations and
limited partnership interests held by or allocable to the Advisor, management of
the Company or any of their respective affiliates based on the aggregate net
asset value of the Company and payable in a hypothetical liquidation of the
Company as of the Valuation Date (which was zero as of December 31, 2022), and
(E) the liquidation value of the outstanding shares of Series A Preferred Stock
and Series B Preferred Stock, divided by (iii) the number of shares of common
stock outstanding as of the Valuation Date, which was 105,541,612. In
determining the Estimated Per-Share NAV, the independent directors of the Board
also considered the impact of other factors described herein that were not
specifically quantified. Shares of common stock outstanding for these purposes
is the sum of shares of common stock outstanding, including vested and unvested
restricted shares, and partnership units of the Company's operating partnership
designated as "OP Units" ("OP Units"), excluding performance-based restricted
partnership units of the Company's operating partnership designated as "Class B
Units" ("Class B Units") because the Advisor concluded that, in a hypothetical
liquidation at such Estimated Per-Share NAV, it may not be entitled to any
incentive fees or Class B Units. The Advisor determined the


--------------------------------------------------------------------------------

Estimated Per-Share NAV in a manner consistent with the definition of fair value
under U.S. generally accepted accounting principles set forth in FASB's Topic
ASC 820, Fair Value Measurements and Disclosures.

Income Capitalization Approach



Kroll estimated a range of "as is" market value for substantially all of the
Real Estate Assets as of December 31, 2022 using primarily the income
capitalization approach, which simulates the reasoning of an investor who views
the cash flows that would result from the anticipated revenue and expense on a
property throughout its projection period. The net income developed in Kroll's
analysis is the balance of potential income remaining after vacancy and
collection loss and operating expenses. This net income was then capitalized at
an appropriate rate to derive an estimate of value (the "Direct Capitalization
Method") or discounted by an appropriate yield rate over a typical projection
period in a discounted cash flow analysis (the "Discounted Cash Flow Method").
The Direct Capitalization Method was used for stabilized real estate assets, and
the Discounted Cash Flow Method was used for real estate assets that were not
stabilized or which had leases with irregular rent escalations. Thus, two key
steps were involved: (i) estimating the net income applicable to each Real
Estate Asset, and (ii) choosing appropriate capitalization rates and discount
rates, as applicable.

Other Approaches

Kroll utilized a sales comparison approach (the "Sales Comparison Approach") to
estimate the market value of the Company's two vacant land parcels based on what
other purchasers and sellers in the applicable market had agreed to as a price
for comparable vacant land parcels. This approach is based on the principle of
substitution, which states that the limits of prices, rents and rates tend to be
set by the prevailing prices, rents and rates of equally desirable substitutes.

Kroll utilized the contract purchase price (the "Acquisition Method") to estimate the value of one recently acquired Medical Office Building.

Kroll utilized the contract sales price (the "Disposition Method") to estimate the value of five Seniors Housing Properties under contract for sale.

Summary of Approaches



Kroll utilized the Discounted Cash Flow Method for 168 Real Estate Assets, the
Direct Capitalization Method for 26 Real Estate Assets, the Disposition Method
for five Real Estate Assets, the Sales Comparison Approach for two Real Estate
Assets and the Acquisition Method for one Real Estate Asset. Excluding the five
properties valued using the Disposition Method, Kroll changed the valuation
approach for six Seniors Housing Properties from Direct Capitalization Method as
of December 31, 2021 to the Discounted Cash Flow Method as of December 31, 2022,
reflecting the fact that the cash flows from these properties were negatively
impacted and are expected to stabilize over time. Also, Kroll changed the
valuation approach for 13 Seniors Housing Properties from the Discounted Cash
Flow Method as of December 31, 2021, to the Direct Capitalization Method as of
December 31, 2022, which reflects cash flow stabilization at these properties.
The following table presents the valuation methodology by property type:

                                                      Income Capitalization Approach                                                             Other Approaches
                                       Discounted Cash Flow                   Direct Capitalization
                                              Method                                 Method                  Acquisition Method               Disposition Method            Sales Comparison Approach           Total
Medical Office Buildings                       147                                      2                             1                               -                                 -                        150
Seniors Housing Properties                      21                                     24                             -                               -                                 2                        47
Properties under contract to be
sold (1)                                        -                                       -                             -                               5                                 -                         5
Total                                          168                                     26                             1                               5                                 2                        202


(1)Consists of five Seniors Housing Properties under contract to be sold, which
is expected to be completed in the second quarter of 2023. There was no effect
given in the valuation for potential reinvestment.



--------------------------------------------------------------------------------

Estimated Per-Share NAV



The following table, prepared by the Advisor, summarizes the individual
components of the low, midpoint and high values of the Real Estate Assets
estimated by Kroll and the Advisor's estimate of the values of the Company's
other assets and liabilities. The Estimated Per-Share NAV approved by the Board
of $14.00 was $0.35 per share above the midpoint of the range provided in the
Kroll Report and considered various factors. See the "Overview" section above
for additional discussion of these considerations. The shares of common stock
outstanding used in the calculation of the Estimated Per-Share Nav were
105,541,612 and 99,717,390 as of December 31, 2022 and 2021, respectively, which
represents an increase of approximately 6% of outstanding shares.

As stated above, issuing dividends in additional shares of common stock will,
all things equal, cause the Estimated Per-Share NAV to decline because the
number of shares outstanding increases when shares of common stock are issued in
respect of a stock dividend; however, because each stockholder will receive the
same proportionate number of new shares, the total value of a common
stockholder's investment, all things equal, will not change assuming no sales or
other transfers.

                                                                  December 31, 2022                                 December 31, 2021
                                                           Range of Values
                                              Low             Midpoint            High             Final                  Final
Real Estate Assets (1)                     $ 24.02          $   24.88          $  25.77          $ 25.23          $            27.43
Other Assets (2)                              0.91               0.91              0.91             0.91                        1.08
Derivative Assets, at fair value (3)          0.39               0.39              0.39             0.39                           -
Fair Value of Debt (4)                      (10.26)            (10.26)           (10.26)          (10.26)                     (10.97)
Derivative Liabilities, at fair
value (3)                                        -                  -                 -                -                       (0.14)
Other Liabilities (5)                        (0.44)             (0.44)            (0.44)           (0.44)                      (0.49)
Series A Preferred Stock (6)                 (0.97)             (0.97)            (0.97)           (0.97)                      (1.00)
Series B Preferred Stock (7)                 (0.86)             (0.86)            (0.86)           (0.86)                      (0.91)
Kroll Range of Values                      $ 12.79          $   13.65          $  14.54          $ 14.00          $            15.00



(1)The low and midpoint values of the Real Estate Assets reflect overall
decreases of 5.4% and 2.0% below, respectively, and the high value of the Real
Estate Assets reflects an overall increase of 1.5% above, the sum of (i) the
aggregate purchase price of the Real Estate Assets of $2.6 billion, and (ii) the
aggregate subsequent capital expenditures for the Real Estate Assets of $122.0
million. The key assumptions that were used by Kroll in its models to estimate
the value of each Real Estate Asset are set forth below:

The following summarizes the range of capitalization rates used to arrive at the
estimated market values of the Real Estate Assets valued utilizing the Direct
Capitalization Method as of December 31, 2022:

                                            Weighted
                            Range            Average
Capitalization Rate     5.50% - 7.75%         6.38%


The following summarizes the range of terminal capitalization rates and discount
rates used to arrive at the estimated market values of the Real Estate Assets
valued utilizing the Discounted Cash Flow Method as of December 31, 2022:

                                                        Weighted
                                        Range            Average
Terminal Capitalization Rate        5.50% - 9.50%         7.04%
Discount Rate                      6.25% - 12.75%         8.20%

(2)Includes the following line items from the Company's audited financial statements: (i) cash and cash equivalents; (ii) restricted cash; and (iii) prepaid expenses and other assets, adjusted for certain items. The Advisor believes that the carrying values of these assets estimate their fair values.



(3)As disclosed in Note 6 - Fair Value of Financial Instruments to the Company's
audited consolidated financial statements in the Company's Annual Report on Form
10-K, the valuation of derivative instruments is determined using a discounted
cash flow analysis on the expected cash flows of each derivative. This analysis
reflects the contractual terms of the derivatives, including the period to
maturity, as well as observable market-based inputs, including interest rate
curves and implied volatilities. In addition, credit valuation adjustments, are
incorporated into the fair values to account for the Company's potential
nonperformance risk and the performance risk of the counterparties. Derivative
assets, at fair value was presented within "Other Assets" as of December 31,
2021, and Derivative Liabilities, at fair value was presented within "Other
Liabilities" as of December 31, 2021.


--------------------------------------------------------------------------------

(4)As disclosed in Note 6 - Fair Value of Financial Instruments to the Company's
audited consolidated financial statements in the Company's Annual Report on Form
10-K, the value of the Company's mortgage notes payable was estimated using a
discounted cash flow analysis. The inputs into the discounted cash flow analysis
were based on the Advisor's experience with similar types of borrowing
arrangements. Advances under the Company's credit facilities are considered to
be reported at fair value, because the interest rates on the credit facilities
vary with changes in SOFR/LIBOR.

(5)Includes the following line items from the Company's audited financial
statements: (i) accounts payable and accrued expenses (including amounts due to
related parties); (ii) deferred rent; and (iii) distributions payable. The
Advisor believes that the carrying values of these liabilities estimate their
fair values.

(6)Series A Preferred Stock was initially issued in December 2019. Amount represents the liquidation value of the 3,977,144 shares of Series A Preferred Stock outstanding as of December 31, 2022 with a liquidation preference of $25.00 per share.

(7)Series B Preferred Stock was initially issued in October 2021. Amount represents the liquidation value of the 3,630,000 shares of Series B Preferred Stock outstanding as of December 31, 2022 with a liquidation preference of $25.00 per share.

Limitations of the Asset Appraisals



The Company believes that the assumptions described herein to estimate the value
of the Real Estate Assets are within the ranges used by market participants
buying and selling similar properties, assuming a willing buyer and a willing
seller, neither being under any compulsion to buy or to sell. The estimated
values of the Real Estate Assets may not, however, represent current market
value or book value. Real properties are currently carried at their amortized
cost basis in the Company's financial statements. The estimated value of the
Real Estate Assets reflected above does not necessarily represent the value the
Company would receive or accept if the Real Estate Assets were marketed for
sale. The market for commercial real estate can and does fluctuate and values
are expected to change in the future. Further, the Estimated Per-Share NAV does
not reflect a liquidity discount for the fact that the shares of common stock
are not currently traded on a national securities exchange, a discount for the
non-assumability or prepayment obligations associated with certain of the
Company's debt obligations and other costs that may be incurred, including any
costs associated with the sale of assets.

As with any methodology used to estimate value, the methodologies employed to
value the Real Estate Assets by Kroll, and used by the Advisor to make
recommendations to the Board, were based upon a number of estimates and
assumptions that may not be accurate or complete, including estimates and
assumptions such as comparable sales, rental and operating expense data,
capitalization or discount rates, and projections of future rent and expenses.
Further, different parties using different assumptions and estimates could
derive a different Estimated Per-Share NAV, which could be significantly
different from this Estimated Per-Share NAV.

The Estimated Per-Share NAV does not reflect "enterprise value" which may include an adjustment for:



•the large number of Real Estate Assets, given that some buyers may be willing
to pay more for a large portfolio than they are willing to pay for each property
in the portfolio separately;

•any other intangible value associated with a going concern; or

•the possibility that shares of common stock could trade at a premium or a discount to the Estimated Per-Share NAV if they were listed on a national securities exchange.

Limitations of the Estimated Per-Share NAV



The Estimated Per-Share NAV does not represent the: (i) the price at which
shares of common stock would trade at on a national securities exchange or a
third party would pay for the Company, (ii) the amount a stockholder would
obtain if he or she tried to sell his or her shares of common stock or (iii) the
amount stockholders would receive if the Company liquidated its assets and
distributed the proceeds after paying all of its expenses and liabilities.
Accordingly, with respect to the Estimated Per-Share NAV, the Company can give
no assurance that:

•a stockholder would be able to resell his or her shares of common stock at Estimated Per-Share NAV;



•a stockholder would ultimately realize distributions per share of common stock
equal to Estimated Per-Share NAV upon liquidation of the Company's assets and
settlement of its liabilities or a sale of the Company;

•shares of common stock would trade at a price equal to or greater than
Estimated Per-Share NAV if they were listed on a national securities exchange or
that a third party would purchase the Company at a value per share of common
stock equal to Estimated Per-Share NAV; or

•the methodology used to establish the Estimated Per-Share NAV would be
acceptable to the Financial Industry Regulatory Authority for use on customer
account statements, or that the Estimated Per-Share NAV will satisfy the
applicable annual valuation requirements under the Employee Retirement Income
Security Act of 1974, as amended ("ERISA") and the Internal Revenue Code of
1986, as amended (the "Code") with respect to employee benefit plans subject to
ERISA and other retirement plans or accounts subject to Section 4975 of the
Code.

Further, the Estimated Per-Share NAV was calculated as of a specific date, and
the value of shares of common stock will fluctuate over time as a result of,
among other things, developments related to individual assets, changes in the
real estate and


--------------------------------------------------------------------------------

capital markets, acquisitions or dispositions of assets and the distribution of proceeds from the sale of real estate to stockholders.

--------------------------------------------------------------------------------

Conclusion



The Estimated Per-Share NAV as of December 31, 2022 of $14.00 was unanimously
adopted by the independent directors of the Board, who comprise a majority of
the Board, on March 31, 2023. The independent directors of the Board based their
conclusions on their review of the Advisor's analysis and recommendation, the
Kroll Report, estimates and calculations and the fundamentals of the Real Estate
Assets. The Board is ultimately and solely responsible for the Estimated
Per-Share NAV. Estimated Per-Share NAV was determined at a moment in time and
will likely change over time as a result of changes to the value of individual
assets as well as changes and developments in the real estate and capital
markets, including changes in interest rates.

Forward-Looking Statements



Certain statements made in this Form 8-K are "forward-looking statements" (as
defined in Section 21E of the Securities Exchange Act of 1934, as amended),
which reflect the Company's expectations regarding future events.
Forward-looking statements involve a number of risks, uncertainties and other
factors that could cause actual results to differ materially from those
contained in forward-looking statements. Such forward-looking statements
include, but are not limited to, market and other expectations, objectives and
intentions, as well as any other statements that are not historical facts.

The Company's potential risks and uncertainties are presented in the section
titled "Item 1-A - Risk Factors" disclosed in our Annual Report on Form 10-K for
the year ended December 31, 2022 filed with the Securities Exchange Commission
(the "SEC") on March 17, 2023 and all other filings with the SEC after that
date. The Company disclaims any obligation to update and revise statements
. . .

© Edgar Online, source Glimpses